↩ Go Back
Need help?

Biotechnology Businesses for Sale and Investment Opportunities in Maharashtra

Showing 1 - 6 of 6 Biotechnology Businesses for Sale and Investment Opportunities in Maharashtra. Buy or Invest in a Biotechnology, Agricultural Biotechnology, Biotech Facility, Biopharma, Bio Diagnostic, Bio Medical Device or a Bio Therapeutic Drug Business.

Filters
  • Biotechnology

  • Maharashtra

  • Fast food / Restaurant/ coffee shops for sale in Jaipur

 

Bio Diagnostics Business Investment Opportunity in Pune, India

Variety of diagnostic kits for healthcare, infertility, drones, agriculture, food, ngs, research and biotechnology.
- Our company is essentially a biotechnology organization that sells proprietary diagnostic kits for healthcare and biotechnology research kits along with services. - These kits allow our customers to evaluate various parameters by themselves. - We have more than 40 in-house researched products. Manufacturing is done at our own premises. - Our products are sold to 32 distributors who further sell them at pharmacies and hospitals across India. Kits are also sold in Saudi Arabia, Dubai, Ukraine, Sudan and Zimbabwe. We do not sell our products directly to any customers. - Revenue plummeted this year due to the effect of the pandemic on the market. - The business is extremely valuable due to our vast array of products, IP, and enormous growth potential in the future.
Variety of diagnostic kits for healthcare, infertility, drones, agriculture, food, ngs, research and biotechnology.
7.0   Pune
Run Rate Sales
USD 1.2 million
EBITDA Margin
10 - 20 %
Financial Investment
USD 600 K for 15%
Contact Business

Bio Diagnostic Franchise Opportunity

Enbiosis Biotechnology, Established in 2021, 13 Franchisees, London Headquartered
  • 10+ introductions
  • 700+ Page Views
  • 200+ Investor Views
- Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.
Enbiosis Biotechnology, Established in 2021, 13 Franchisees, London Headquartered
9.5   Expanding in India
Exp Monthly Sales
USD 190 thousand
Space Required
0 - 80 Sq Ft
Investment Required
USD 60 K
Contact Company

Biotechnology Company Seeking Loan in Pune, India

Manufactures of research-based biotech inputs for building disease resistance in plants is seeking business loan.
- Globally unique technology under patenting. - Promoter has 20 years experience of developing new products. - Received grants and awards from DBT, DST, Millennium Alliance of about Rs 1 cr. - Grew at 3X from 13-14 till 15-16. This year, the business is a little down due to erratic rains, and first pivot in vegetable market. - However, business is cash plus and growing organic. - 5500 clients in pomegranate and 1500 in vegetables used our products in 3 years of commercialization.
Manufactures of research-based biotech inputs for building disease resistance in plants is seeking business loan.
8.7   Pune
Run Rate Sales
USD 140 thousand
EBITDA Margin
34 %
Business Loan
USD 60 K at 16%
Contact Business

Biotechnology Company Investment Opportunity in Pune, India

Company conducting clinical trials for nutraceuticals, herbal and cosmetic products seeks investment.
- Have catered to 60+ clients. We have clients from 6 different countries. - We have tied up with a network of 150 hospitals across 30 cities to conduct the trials. - The clinical trials are conducted in multiple sites. - We have 13 ongoing collaborations with pharmaceutical companies or research institutions. - Average duration of the clinical trials is 5 months. - We abide by the ICH-GCP guidelines to handle the confidentiality and privacy of participants' data during and after the trial. - One project takes 4-5 months and we receive the entire amount post-completion of the project itself.
7.2   Pune
Run Rate Sales
USD 360 thousand
EBITDA Margin
20 %
Financial Investment
USD 240 K for 2%
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Navi Mumbai, India

Seeking Investment: US FDA approved R&D company with 5+ pharma clients in Europe.
- We do the R&D for big pharma companies. - Innovative formulation development with a focus on quality-by-design principles for precise and effective therapeutic solutions. - Commitment to excellence reflected in crafting products that redefine healthcare standards. - Fusion of innovation and precision, guided by scientific rigor, transforming pharmaceutical science into life-changing solutions. - Expertise in product development, CDMO, CMO, and TT services for five major clients, including big pharma companies. - Promoters bring 15 years of experience in R&D and product development. - Client base includes European companies, demonstrating international reach. - Regulatory approvals from the FDA and ISO 17025 underscore the company's commitment to quality and compliance. - Adaptive workforce with contract workers based on demand. - High growth attributed to the acquisition of new clients, showcasing the company's expanding market presence.
6.5   Navi Mumbai
Run Rate Sales
USD 700 thousand
EBITDA Margin
40 %
Financial Investment
USD 1.2 Mn for 10%
Contact Business

Bio Therapeutic Drugs Company Investment Opportunity in Pune, India

Biopharma company having rights of 15 formulations looking to establish a manufacturing unit in USA.
- We are a biopharma company dealing in the research and development of various formulations and clinical trials. - As of now the company has rights of 15 formulations and has a large market share in this industry. - Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology. - These patients especially travel to India for our treatments. - We don't have our own clinics but subcontract hospitals in Mumbai to use our technology. - Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them. - We also have discussions going on with various insurance companies to provide coverage for our treatments. - Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there. - This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets. - The company has two partners with a 70% and 30% stake distribution. - Business has not taken any loans previously. - We are seeking investment to establish the manufacturing unit.
7.7   Pune
Run Rate Sales
USD 100 thousand
EBITDA Margin
30 %
Financial Investment
USD 800 K for 30%
Contact Business

Frequently
Asked
Questions

  • How many biotechnology businesses for sale and investment opportunities in Maharashtra are listed on SMERGERS?
    There are 6 active and verified biotechnology businesses for sale and investment opportunities in Maharashtra listed on SMERGERS as of 29 March 2024.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more